share_log

JonesTrading Initiates Coverage On Cullinan Oncology With Buy Rating, Announces Price Target of $22

Benzinga ·  Oct 6, 2023 05:50

JonesTrading analyst Soumit Roy initiates coverage on Cullinan Oncology (NASDAQ:CGEM) with a Buy rating and announces Price Target of $22.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment